Adamas Pharma says its new Parkinson’s drug isn’t just a more expensive, long-acting version of generic By: MarketWatch August 29, 2017 at 13:07 PM EDT Adamas’ Gocovri will cost between $10,000 and $30,000 a year. Read More >> Related Stocks: Adamas Pharma Allergan Plc